Literature DB >> 20881503

Human kidney histopathology in acute obstructive jaundice: a prospective study.

Adam Uslu1, Funda Alkan Taşli, Ahmet Nart, Hakan Postaci, Ahmet Aykas, Hasan Bati, Yavuz Coşkun.   

Abstract

INTRODUCTION: Cholemia and bacterial translocation with portal endotoxemia are integral in the pathogenesis of obstructive jaundice (OJ). There is sufficient experimental data about hemodynamic and histopathological consequences of OJ. In contrast, pathological information of renal changes in patients with OJ is still lacking. Therefore; the primary objective of this prospective study is to show the specific histopathological changes in kidneys of patients with short-term biliary tract obstruction receiving a standard perioperative medical treatment protocol.
MATERIALS AND METHODS: Twenty consecutive patients with biliary obstruction were included in the study. Fluid replacement, prevention of biliary sepsis, and portal endotoxemia were mainstays of the perioperative treatment protocol. Fluid and electrolyte balance was maintained by twice daily body weight calculations, central venous pressure, and mean arterial pressure monitoring. Renal function was assessed by glomerular filtration rate estimation by modification of diet in renal disease-7 formula. Kidney biopsy evaluation was focused on tubular changes, thrombotic microangiopathy, endothelial damage, and peritubular capillary (PTC) dilatation with or without C4d staining. Fresh frozen sections were evaluated with immunofluorescence microscopy for glomerular IgG, IgA, IgM, C3, and C1q staining.
RESULTS: The mean duration of OJ was 15.5 ± 1.4 days. Body weight increased before surgery through volume expansion (P = 0.001). All patients have shown mean arterial pressure ≥ 70 and ≤ 120 mmHg and renal function was very well preserved in all but one subject during the perioperative period. Despite those favorable figures, dilatation of peritubular venules and acute tubular necrosis were shown synchronously in all cases. C4d staining in PTC and arterioles and thrombotic microangiopathy were entirely absent in the study group. Immune complex deposits in PTCs and in glomeruli were not detected. Three patients had isolated glomerular C4d deposition without accompanying thrombotic microangiopathy and IgG, IgA, IgM, C3, and C1q staining of glomerular capillaries in I immunofluorescence microscopy. DISCUSSION: This study is the first in the literature to address the histopathological changes that occur in humans with short-term biliary obstruction. Acute tubular necrosis and venous dilatation was observed in all biopsies, without exception, despite the maintenance of strict volume control in all patients. The adequacy of volume control may not be implicated in those results; rather a possible mechanism related to untrapped endotoxin in the gut lumen or systemic circulation might lead to prolonged PTC dilatation and hypoperfusion with synchronous acute tubular necrosis. Absolute recovery of renal function in all patients and the demonstration of solitary acute tubular necrosis with no microvascular-glomerular-interstitial inflammation or injury, suggests that the perioperative treatment regime in this study is fairly efficacious in short-term OJ.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881503     DOI: 10.1097/MEG.0b013e32833f71f6

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  10 in total

1.  Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression.

Authors:  Er-Liang Kong; Jin-Min Zhang; Ni An; Yong Tao; Wei-Feng Yu; Fei-Xiang Wu
Journal:  J Cell Commun Signal       Date:  2018-06-07       Impact factor: 5.782

Review 2.  Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.

Authors:  Juan Carlos Q Velez; George Therapondos; Luis A Juncos
Journal:  Nat Rev Nephrol       Date:  2019-11-13       Impact factor: 28.314

3.  Efficacy of extracorporeal albumin dialysis for acute kidney injury due to cholestatic jaundice nephrotoxicity.

Authors:  Florence Sens; Justine Bacchetta; Maud Rabeyrin; Laurent Juillard
Journal:  BMJ Case Rep       Date:  2016-07-07

Review 4.  Bile Cast Nephropathy: A Comprehensive Review.

Authors:  Manoj R Somagutta; Molly S Jain; Maria Kezia Lourdes Pormento; Siva K Pendyala; Narayana Reddy Bathula; Nagendrababu Jarapala; Ashwini Mahadevaiah; Nayana Sasidharan; Mohamed A Gad; Greta Mahmutaj; Namrata Hange
Journal:  Cureus       Date:  2022-03-29

5.  Evaluation of qSOFA score, and conjugated bilirubin and creatinine levels for predicting 28-day mortality in patients with sepsis.

Authors:  Yufei Xiao; Xiaotian Yan; Lingwei Shen; Qi Wang; Fugang Li; Dan Yang; Weiwei Wu; Yun Qian
Journal:  Exp Ther Med       Date:  2022-05-16       Impact factor: 2.751

Review 6.  Should preoperative biliary drainage be routinely performed for obstructive jaundice with resectable tumor?

Authors:  Chu Wang; Yiyao Xu; Xin Lu
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

7.  The Role of e-NOS in Chronic Cholestasis-Induced Liver and Renal Injury in Rats: The Effect of N-Acetyl Cysteine.

Authors:  Yusuf Gunay; Semsi Altaner; Nergiz Ekmen
Journal:  Gastroenterol Res Pract       Date:  2014-11-09       Impact factor: 2.260

8.  Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study.

Authors:  Suman Lata Nayak; Manoj Kumar; Chhagan Bihari; Archana Rastogi
Journal:  J Clin Transl Hepatol       Date:  2017-05-04

9.  Adaptive Mechanisms of Renal Bile Acid Transporters in a Rat Model of Carbon Tetrachloride-Induced Liver Cirrhosis.

Authors:  Chiara Donadei; Andrea Angeletti; Maria Cappuccilli; Massimiliano Conti; Diletta Conte; Fulvia Zappulo; Alessio De Giovanni; Deborah Malvi; Rita Aldini; Aldo Roda; Gaetano La Manna
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

10.  Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction.

Authors:  Basil Alnasrallah; John F Collins; L Jonathan Zwi
Journal:  Case Rep Nephrol       Date:  2016-02-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.